Motley Fool  Aug 17  Comment 
RA Capital Management has shifted from selling Achillion's shares to buying them, suggesting the worst may be over for this company.
Benzinga  Aug 3  Comment 
Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN) announced today that Alios Biopharma Inc., part of the Janssen Pharmaceutical Companies (NYSE: JNJ) has initiated a phase I clinical trial to evaluate the potential effect of simeprevir and odalasvir...
Benzinga  Jun 22  Comment 
Biotie Therapies Corp. (NASDAQ: BITI) shares declined 9.90 percent to $21.65 in pre-market trading after jumping 10.23 percent on Friday. Ambarella Inc (NASDAQ: AMBA) fell 3.23 percent to $115.50 in pre-market trading after dropping 5.80...
Market Intelligence Center  May 22  Comment 
Eleven Biotherapeutics EBIO suffered a huge setback with its lead pipeline candidate failing in a late-stage study. Meanwhile, companies like bluebird BLUE, Agios AGIO and Acceleron XLRN all got encouraging news on the regulatory front. Achillion...
Motley Fool  May 20  Comment 
Achillion Pharmaceuticals, Inc. investors are disappointed that Johnson & Johnson isn't buying the company outright.
Benzinga  May 20  Comment 
Lpath, Inc. (NASDAQ: LPTN) shares dropped 75.44 percent to $0.420 after the company announced its plans to cut jobs as its multicenter, Phase 2 Nexus clinical trial evaluating iSONEP™ in patients with wet age-related macular degeneration did...
TheStreet.com  May 20  Comment 
NEW YORK (TheStreet) -- Shares of Achillion Pharmaceuticals are plummeting, down 12.83% to $9.31 in early market trading Wednesday, as the company gets downgraded by analysts at JMP Securities to "market perform" from "market outperform" on...

You may also be interested in articles related to Achillion Pharmaceuticals (ACHN):


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki